IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.8% | -21.4% | -2.7% | +4.3% | +65.6% | -12.8% | +13.8% | +5.7% | -4.7% | +12.1% | +5.4% | – | |
| – | -27.1% | -23.7% | -56.5% | +75.2% | +55.1% | -11.3% | +3.5% | +3.4% | +38.4% | -14.7% | +7.5% | – | |
| – | – | +801.8% | -215.7% | – | -824.4% | – | – | – | +55.8% | -49.9% | -226.4% | – | |
| – | – | +41.2% | +695.8% | +12.6% | -0.5% | +43.5% | +13.7% | +200.9% | +40.9% | -58.6% | +27.1% | – | |
| – | -1,153.7% | -98.1% | +695.8% | -54.5% | +141.4% | +46.2% | +13.7% | +200.9% | +40.9% | -58.6% | +27.1% | – | |
| – | – | – | -582.0% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -4.7% | +19.5% | +16.3% | +5.3% | +50.0% | -20.6% | +6.3% | – | |
| – | -100.2% | +0.0% | – | -102.6% | – | +163.5% | -100.4% | +5.3% | +110.0% | – | -102.3% | – | |
| – | -164.4% | – | – | -260.2% | – | +324.7% | -130.1% | – | – | – | -163.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.